APA (7th ed.) Citation

Matsuda, H., Hiramatsu, K., Akazawa, Y., Nosaka, T., Saito, Y., Ozaki, Y., . . . Nakamoto, Y. (2018). Genetic polymorphism and decreased expression of HLA class II DP genes are associated with HBV reactivation in patients treated with immunomodulatory agents. Journal of medical virology, 90(4), 712-720. https://doi.org/10.1002/jmv.25011

Chicago Style (17th ed.) Citation

Matsuda, Hidetaka, et al. "Genetic Polymorphism and Decreased Expression of HLA Class II DP Genes Are Associated with HBV Reactivation in Patients Treated with Immunomodulatory Agents." Journal of Medical Virology 90, no. 4 (2018): 712-720. https://doi.org/10.1002/jmv.25011.

MLA (9th ed.) Citation

Matsuda, Hidetaka, et al. "Genetic Polymorphism and Decreased Expression of HLA Class II DP Genes Are Associated with HBV Reactivation in Patients Treated with Immunomodulatory Agents." Journal of Medical Virology, vol. 90, no. 4, 2018, pp. 712-720, https://doi.org/10.1002/jmv.25011.